Morgan Stanley’s Stress Capital Buffer Adjustment
In a significant regulatory update, the Federal Reserve announced a reduction in Morgan Stanley‘s Stress Capital Buffer (SCB) from 5.1% to 4.3%. This change will take effect on October 1, 2025, and comes after the firm requested a reassessment of its preliminary SCB, which was initially disclosed in June 2025. This adjustment is part of a broader regulatory capital framework that leads to an overall U.S. Basel III Standardized Approach Common Equity Tier 1 (CET1) ratio of 11.8%. For context, Morgan Stanley‘s CET1 ratio stood at 15.0% as of June 30, 2025, reflecting a solid capital position prior to this modification.
Response from Morgan Stanley’s Leadership
Commenting on this development, Sharon Yeshaya, who serves as the Executive Vice President and Chief Financial Officer of Morgan Stanley, expressed gratitude for the Federal Reserve‘s careful review of the firm’s 2025 Comprehensive Capital Analysis and Review (CCAR) results. Yeshaya emphasized the firm’s commitment to engaging constructively with the Federal Reserve regarding the stress testing framework. She noted that Morgan Stanley remains dedicated to maintaining its long-term capacity to support its global clientele while also investing in its core business areas and ensuring the steady growth of its quarterly dividend.
About Morgan Stanley
Founded in 1935, Morgan Stanley is a prominent global financial services firm that offers a comprehensive array of services, including investment banking, securities, wealth management, and investment management. With a presence in 42 countries, the firm caters to a diverse range of clients, including corporations, governments, institutions, and individual investors. For more detailed information about Morgan Stanley, interested parties are encouraged to visit their official website.
Forward-Looking Statements and Investor Caution
It is important to note that this announcement includes forward-looking statements as defined by the U.S. Private Securities Litigation Reform Act of 1995. Readers are advised to be cautious about placing undue reliance on these statements, as they reflect the management’s current views and expectations regarding future results and regulatory capital levels. The actual outcomes may differ significantly due to various risks and uncertainties. For a comprehensive discussion of these risks, stakeholders can refer to the Morgan Stanley‘s Annual Report on Form 10-K and other regulatory filings.
In summary, the adjustment of the Stress Capital Buffer represents an important development for Morgan Stanley as it navigates the complexities of financial regulation while striving to enhance its operational stability and shareholder value.
Related
